Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on: December 28,2023

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on:December 28,2023

Study explains how 'zombie' cancer cells revive themselves

by Andrew Smith,Rutgers UniversityGraphical abstract. Credit:Cell Genomics(2023). DOI: 10.1016/j.xgen.2023.100293Mutating cells can prevent the spread of cancer by flipping themselve

Updated on: February 03,2024

Study explains how 'zombie' cancer cells revive themselves

by Andrew Smith,Rutgers UniversityGraphical abstract. Credit:Cell Genomics(2023). DOI: 10.1016/j.xgen.2023.100293Mutating cells can prevent the spread of cancer by flipping themselve

Updated on:February 03,2024

Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen

Updated on: February 03,2024

Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen

Updated on:February 03,2024

Putting the brakes on tumor stealth

by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how

Updated on: April 01,2024

Putting the brakes on tumor stealth

by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how

Updated on:April 01,2024

Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

by Massachusetts General HospitalMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaA Massachusetts G

Updated on: April 01,2024

Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

by Massachusetts General HospitalMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaA Massachusetts G

Updated on:April 01,2024

New imaging technique improves accuracy of diagnosis for most common skin cancer

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainA novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC)—the mos

Updated on: January 11,2024

New imaging technique improves accuracy of diagnosis for most common skin cancer

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainA novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC)—the mos

Updated on:January 11,2024

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on: April 06,2024

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on:April 06,2024

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi

Updated on: August 01,2024

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi

Updated on:August 01,2024

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on: January 15,2024

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on:January 15,2024

'Tumor progressing,' 'Positive findings': Patients often confused by medical jargon

by Amy NortonIf you've ever left a medical appointment confused, it's probably not you: A new study finds that the medical jargon doctors use can be completely misunderstood by patients.Common

Updated on: January 22,2024

'Tumor progressing,' 'Positive findings': Patients often confused by medical jargon

by Amy NortonIf you've ever left a medical appointment confused, it's probably not you: A new study finds that the medical jargon doctors use can be completely misunderstood by patients.Common

Updated on:January 22,2024

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot

Updated on: August 03,2024

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot

Updated on:August 03,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on: March 30,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on:March 30,2024